ISG20 and central nervous system cancer: Furthermore, the stratification analysis showed that high ISG20 expression may predict unfavorable OS in glioma patient subgroups with different age, sex, IDH mutation, 1p19q codeletion, and MGMT methylation (all P < 0.05; Fig. 4C-G).